UB Paderborn / Katalog / Suche / in CDI

1 – 24 von 24

Sortiert nach

Selective induction of cancer cell death by VDAC1‐based peptides and their potential use in cancer therapy

Molecular oncology, 2018-06, Vol.12 (7), p.1077-1103

2018

Volltextzugriff (PDF)

SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis

Molecular oncology, 2021-11, Vol.15 (11), p.3037-3061

2021

Volltextzugriff (PDF)

VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases

Biomolecules (Basel, Switzerland), 2020-10, Vol.10 (11), p.1485

2020

Volltextzugriff (PDF)

Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity

The Journal of biological chemistry, 2010-02, Vol.285 (9), p.6053-6062

2010

Volltextzugriff (PDF)

Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics

Frontiers in oncology, 2017-07, Vol.7, p.154-154

2017

Volltextzugriff (PDF)

Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?

Frontiers in physiology, 2021-10, Vol.12, p.730048

2021

Volltextzugriff (PDF)

Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells

Molecular therapy. Nucleic acids, 2019-09, Vol.17, p.24-37

2019

Volltextzugriff (PDF)

VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress

Cell Stress, 2017-10, Vol.1 (1), p.11-36

2017

Volltextzugriff (PDF)

Uncovering the role of VDAC in the regulation of cell life and death

Journal of bioenergetics and biomembranes, 2008-06, Vol.40 (3), p.183-191

2008

Volltextzugriff (PDF)

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo

Molecular therapy. Nucleic acids, 2014, Vol.3 (4), p.e159-e159, Article e159

2014

Volltextzugriff (PDF)

Overexpression of the mitochondrial anti-viral signaling protein, MAVS, in cancers is associated with cell survival and inflammation

Molecular therapy. Nucleic acids, 2023-09, Vol.33, p.713-732

2023

Volltextzugriff (PDF)

The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link

Cancers, 2020-04, Vol.12 (4), p.1031

2020

Volltextzugriff (PDF)

Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks

Biomolecules (Basel, Switzerland), 2022-06, Vol.12 (7), p.895

2022

Volltextzugriff (PDF)

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets

Frontiers in oncology, 2022-06, Vol.12, p.949139-949139

2022

Volltextzugriff (PDF)

Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract

Cancers, 2023-03, Vol.15 (5), p.1627

2023

Volltextzugriff (PDF)

Downregulation of voltage-dependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivo

Cancer biology & therapy, 2010-06, Vol.9 (12), p.1046-1052

2010

Volltextzugriff (PDF)

Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept

Cells (Basel, Switzerland), 2019-10, Vol.8 (11), p.1330

2019

Volltextzugriff (PDF)

Editorial: Uncovering the Function of the Mitochondrial Protein VDAC in Health and Disease: From Structure-Function to Novel Therapeutic Strategies

Frontiers in oncology, 2017-12, Vol.7, p.320-320

2017

Volltextzugriff (PDF)

Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment

PloS one, 2016-04, Vol.11 (4), p.e0148500-e0148500

2016

Volltextzugriff (PDF)

The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide

Biomolecules (Basel, Switzerland), 2022-09, Vol.12 (10), p.1387

2022

Volltextzugriff (PDF)

Apoptotic proteins with non-apoptotic activity: expression and function in cancer

Apoptosis (London), 2023-06, Vol.28 (5-6), p.730-753

2023

Volltextzugriff (PDF)

The mitochondrial voltage-dependent anion channel 1 in tumor cells

Biochimica et biophysica acta, 2015-10, Vol.1848 (10), p.2547-2575

2015

Volltextzugriff (PDF)

Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein

The Journal of biological chemistry, 2012-06, Vol.287 (27), p.23152-23161

2012

Volltextzugriff (PDF)

A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis

Molecular therapy, 2018-03, Vol.26 (3), p.680-694

2018

Volltextzugriff (PDF)

1 – 24 von 24

Suche als RSS-Feed

Aktive Filter

ThemaCancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)

Sprache

Englisch
(24)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(23)
Mitochondria
(21)
Apoptosis
(20)
Metabolism
(16)
Proteins
(12)
Humans
(10)
Vdac1
(10)
Oncology
(9)
Metabolites
(8)
Biochemistry & Molecular Biology
(7)
Mitochondria - Metabolism
(6)
Stem Cells
(6)
Tumors
(6)
Voltage-Dependent Anion Channel 1 - Metabolism
(6)
Cell Differentiation
(5)
Cell Growth
(5)
Cell Proliferation
(5)
Neoplasms - Metabolism
(5)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Selective induction of cancer cell death by VDAC1‐based peptides and their potential use in cancer therapy

SMAC/Diablo controls proliferation of cancer cells by regulating phosphatidylethanolamine synthesis

VDAC1 at the Intersection of Cell Metabolism, Apoptosis, and Diseases

Voltage-dependent Anion Channel 1-based Peptides Interact with Bcl-2 to Prevent Antiapoptotic Activity

Voltage-Dependent Anion Channel 1 As an Emerging Drug Target for Novel Anti-Cancer Therapeutics

Adverse Effects of Metformin From Diabetes to COVID-19, Cancer, Neurodegenerative Diseases, and Aging: Is VDAC1 a Common Target?

Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells

VDAC1 at the crossroads of cell metabolism, apoptosis and cell stress

Uncovering the role of VDAC in the regulation of cell life and death

Silencing VDAC1 Expression by siRNA Inhibits Cancer Cell Proliferation and Tumor Growth In Vivo

Overexpression of the mitochondrial anti-viral signaling protein, MAVS, in cancers is associated with cell survival and inflammation

The Mitochondrial Protein VDAC1 at the Crossroads of Cancer Cell Metabolism: The Epigenetic Link

Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks

Editorial: Altered Expression of Proteins in Cancer: Function and Potential Therapeutic Targets

Pro-Apoptotic and Anti-Cancer Activity of the Vernonanthura Nudiflora Hydroethanolic Extract

Downregulation of voltage-dependent anion channel-1 expression by RNA interference prevents cancer cell growth in vivo

Rewiring of Cancer Cell Metabolism by Mitochondrial VDAC1 Depletion Results in Time-Dependent Tumor Reprogramming: Glioblastoma as a Proof of Concept

Editorial: Uncovering the Function of the Mitochondrial Protein VDAC in Health and Disease: From Structure-Function to Novel Therapeutic Strategies

Novel Biomarker Proteins in Chronic Lymphocytic Leukemia: Impact on Diagnosis, Prognosis and Treatment

The Multicellular Effects of VDAC1 N-Terminal-Derived Peptide

Apoptotic proteins with non-apoptotic activity: expression and function in cancer

The mitochondrial voltage-dependent anion channel 1 in tumor cells

Mediation of the Antiapoptotic Activity of Bcl-xL Protein upon Interaction with VDAC1 Protein

A New Role for the Mitochondrial Pro-apoptotic Protein SMAC/Diablo in Phospholipid Synthesis Associated with Tumorigenesis

Aktive Filter

Suchergebnisse filtern